Last updated on June 2009

You may be eligible to join the EMERGE STUDY if you

Brief description of study

You may be eligible to join the EMERGE STUDY if you

Detailed Study Description

  • Are between 18 and 75 years old
  • Have been taking a stable dose of pioglitazone ≥ 30 mg/day and metformin ≥ 1,500 mg/day (or the maximum tolerated dose or maximum dose specified on the label) for at least 12 months
  • Have had no treatment with insulin for longer than 1 week during the past 6 months
  • Have weighed about the same for at least 12 weeks
  • Agree to maintain you current diet and exercise habits throughout your participation in the study

If you decide to join the study, you will be asked to:

  • Take your study medication (by injection) once a week for up to 52 weeks
  • Atted up to 11 study visits during a 1-year period and participate in a follow-up telephone visit
  • Undergo study-related procedures, including:
    • Blood draws and urine samples
    • Physical examinations (including weight and waist/hip circumference measurement
    • Vital signs (blood pressure, heart rate)
    • ECG testing
    • Glucose testing
  • Monitor your glucose levels at home
  • Maintain a study diary

To find out more and to see if you qualify, please call:

Clinical Study Identifier: TX134450

Contact Investigators or Research Sites near you

Start Over

Diablo Clinical Research

Diablo Clinical Research
Walnut Creek, CA USA
  Connect »